Pharmacological profile of a new antilipolytic agent: 5-methyl-pyrazine-2-carboxylic acid 4-oxide (acipimox) II — Antilipolytic and blood lipid lowering activity
- 1 February 1981
- journal article
- research article
- Published by Elsevier in Pharmacological Research Communications
- Vol. 13 (2), 163-174
- https://doi.org/10.1016/s0031-6989(81)80017-3
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Pharmacological profile of a new anti-lipolytic agent: 5-methyl-pyrazine-2-carboxylic acid 4-oxide (acipimox) I — Mechanism of actionPharmacological Research Communications, 1981
- Potentiation of ethanol fatty liver in rats by chronic administration of nicotinic acidBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1976
- γ-Hydroxybutyrate in Mammalian BrainPublished by Elsevier ,1964
- Determination of serum triglyceridesJournal of Atherosclerosis Research, 1963
- An o-Toluidine Method for Body-Fluid Glucose DeterminationClinical Chemistry, 1962
- A SIMPLIFIED METHOD FOR THE ESTIMATION OF TOTAL CHOLESTEROL IN SERUM AND DEMONSTRATION OF ITS SPECIFICITYJournal of Biological Chemistry, 1952